Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Malindo Feedmill Tbk. (MAIN) vs Merck Tbk. (MERK) Price & Performance

Malindo Feedmill Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Malindo Feedmill Tbk. vs Merck Tbk. — how do they compare? Malindo Feedmill Tbk. trades at Rp670 (market cap 1.54T, 1.9M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Malindo Feedmill Tbk. and Merck Tbk. are close in size by market cap, and Malindo Feedmill Tbk. is more actively traded (1.9M versus 63K). Which is the better fit depends on your goals.

MAINMERK
Market Cap
1.54T1.76T
Volume
1.9M63K
Lot
19.02K630
Turnover
1.28B243.97M
Average Price
674.353,872.46
Value
1.28B243.97M
Indicative Equilibrium Price
6703,900
Indicative Equilibrium Volume
3021

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MAIN
View details
MERK
View details

About Malindo Feedmill Tbk.

PT Malindo Feedmill Tbk (the Company) was established within the framework of Law No. 1 of 1967 and Law No. 11 of 1970 regarding Foreign Capital Investment. The Company was established under its original name PT Gymtech Feedmill on June 10, 1997. The company's name changed to PT Malindo Feedmill in year 2000. The company’s articles of association were amended several times, the lates on Jul 28 2005, regarding among other increasing in paid up capital share.

Read more on MAIN

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK